Recent literature evidence suggests that melanoma and colorectal cancer possess high Dicer expression that correlated with poor patient prognosis, while low Dicer expression in breast cancer correlated with poor patient prognosis [22, 23, 54]. This evidence concerns the gene DICER1 and breast cancer.